ACS CAN’s Pam Traxel joins WPP’s Wendy Lund to unpack what patients need most amid growing complexity in cancer care.

The biopharma dealmaking landscape and what to expect in 2026

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;